These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Respiratory epithelial adenomatoid hamartoma with nasal polyps affects dupilumab efficacy. Takeda T; Yanagi N; Fukasawa N; Mori E; Maeda M; Sakaguchi R; Tei M; Omura K; Otori N Rhinology; 2022 Apr; 60(2):148-151. PubMed ID: 35174813 [No Abstract] [Full Text] [Related]
11. Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis. Bachert C; Zhang L; Gevaert P J Allergy Clin Immunol; 2015 Dec; 136(6):1431-1440. PubMed ID: 26654192 [TBL] [Abstract][Full Text] [Related]
12. Dupilumab: First Global Approval. Shirley M Drugs; 2017 Jul; 77(10):1115-1121. PubMed ID: 28547386 [TBL] [Abstract][Full Text] [Related]
13. Recalcitrant nasal polyposis: achievement of total remission following treatment with omalizumab. Guglielmo M; Gulotta C; Mancini F; Sacchi M; Tarantini F J Investig Allergol Clin Immunol; 2009; 19(2):158-9. PubMed ID: 19476021 [No Abstract] [Full Text] [Related]
14. Subcutaneous Dupilumab and Mometasone Furoate Nasal Spray for Chronic Rhinosinusitis With Polyps. Schneider JS JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):698-9. PubMed ID: 27258602 [No Abstract] [Full Text] [Related]
15. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. Gevaert P; Van Bruaene N; Cattaert T; Van Steen K; Van Zele T; Acke F; De Ruyck N; Blomme K; Sousa AR; Marshall RP; Bachert C J Allergy Clin Immunol; 2011 Nov; 128(5):989-95.e1-8. PubMed ID: 21958585 [TBL] [Abstract][Full Text] [Related]
16. State of the art treatment of nasal polyposis. Aouad RK; Chiu AG Am J Rhinol Allergy; 2011; 25(5):291-8. PubMed ID: 22186240 [TBL] [Abstract][Full Text] [Related]
17. [Progress of monoclonal antibody treatment for chronic rhinosinusitis with or without nasal polyps]. Chen YJ; Chai XB Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 32(10):789-793. PubMed ID: 29873221 [TBL] [Abstract][Full Text] [Related]
19. Authors' Reply: Sinonasal polyposis recurrence rate and quality of life in the elderly. Brescia G; Barion U; Marioni G Am J Rhinol Allergy; 2017 Jan; 31(1):2. PubMed ID: 28234139 [No Abstract] [Full Text] [Related]
20. Biologic Agents for the Treatment of Chronic Rhinosinusitis With Nasal Polyps. Kartush AG; Schumacher JK; Shah R; Patadia MO Am J Rhinol Allergy; 2019 Mar; 33(2):203-211. PubMed ID: 30587005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]